Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Abbott India appoints Devesh Choudhari as Director - Finance

Ruchika Sharma1 April 2025 1:02 PM IST

Mumbai: Abbott India has announced the appointment of Devesh Choudhari as Director - Finance effective April 1, 2025. He will be joining the...

Wockhardt posts profit of Rs 82 crore in Q2

Wockhardt Zaynich successfully treats paediatric cancer patient with recalcitrant blood, liver infection

Ruchika Sharma1 April 2025 12:15 PM IST

The patient was treated with Zaynich for 41 days, resulting in the successful resolution of the infection.

Govt extends deadline for submitting applications under PLI Scheme

Morepen Labs receives anti-allergy API Loratadine approval for export to China

Ruchika Sharma1 April 2025 11:15 AM IST

This marks a Morepen's strategic entry into one of the world's largest pharmaceutical markets.

Eli Lilly in Talks to Acquire Ventyx Biosciences in USD 1 Billion-Plus Deal

Eli Lilly Alzheimer's drug rejected by EU regulator

Ruchika Sharma31 March 2025 5:20 PM IST

Indianapolis: Indianapolis-based pharmaceutical giant Eli Lilly has faced a setback as the European Union's drug regulator rejected its...

Shilpa Medicare ink pact to sell 31 percent stake in Sravathi Advanced Process Technologies for Rs 49.6 crore

KKR divests 5.8 percent stake in JB Chemicals & Pharma for Rs 1460 crore

Ruchika Sharma31 March 2025 4:44 PM IST

New Delhi: KKR, the U.S.-based private equity giant, has divested a 5.8 per cent stake in JB Chemicals & Pharmaceuticals for Rs 1,460 crore...

USFDA top vaccine official Peter Marks forced out

Ruchika Sharma31 March 2025 4:15 PM IST

Bengaluru: Peter Marks, the top vaccine official at the U.S. Food and Drug Administration (USFDA) has been pushed out of his role, the Wall Street...

Novartis appoints Karen Hale as Chief Legal and Compliance Officer

Ruchika Sharma31 March 2025 2:55 PM IST

Basel: Novartis has announced the appointment of Karen Hale to the expanded role of Chief Legal and Compliance Officer for Novartis, effective...

US District Court grants summary judgement in favour of SPARC for Sezaby PRV

Sun Pharma Advanced Research Company submits IND application for SBO-154 to USFDA

Ruchika Sharma31 March 2025 1:09 PM IST

Mumbai: Sun Pharma Advanced Research Company Ltd. has announced submission of an Investigational New Drug (IND) application with the US...

Bal Krishan Saini designated as Senior Management Personnel of Panacea Biotec Pharma

Panacea Biotec: Manjula Upadhyay ceases to be Independent Director, Chairperson/member of Committees of Board of Directors

Ruchika Sharma31 March 2025 11:30 AM IST

New Delhi: Panacea Biotec Limited has announced that Manjula Upadhyay, Independent Director of the Company, has completed her second and...

Medicines worth Rs 6,975 crore in MRP terms sold through JAKs in last 10 years

Ruchika Sharma30 March 2025 2:15 PM IST

New Delhi: Under Pradhan Mantri Bhartiya Janaushadhi Pariyojana scheme, quality generic medicines are being made available through a network of over...

Bristol Myers Squibb Breyanzi approved by USFDA for adults with Marginal Zone Lymphoma

Bristol Myers Squibb receives positive EMA Committee opinion for Perioperative Opdivo plus Chemo in Resectable Non-Small Cell Lung Cancer plus PD-L1

Ruchika Sharma30 March 2025 12:15 PM IST

Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...

Sanofi Dupixent approved in Japan for COPD

Ruchika Sharma30 March 2025 10:00 AM IST

Dupixent is intended for injection under the skin (subcutaneous injection) and is given every other week.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok